Mark Devlin

Mark Devlin is a dynamic leader with extensive experience in pharmaceutical sales, marketing, and market access. Currently serving as the Head of Market Access at Phathom Pharmaceuticals, they are responsible for pricing, market access strategy, and commercial readiness for a lead Phase 3 asset. Prior to this role, Mark held senior positions at Allergan and Forest Laboratories, where they successfully launched major products and developed market access strategies. As President of Devco Consulting LLC, they focus on business consulting in the biopharmaceutical industry. Mark holds a B.S. in Biology/Chemistry from Fairleigh Dickinson University and an MBA from Babson College.